Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for PsychosisClinical High Risk for Psychosis (CHR)RecruitingPhase 1 / Phase 22026-06-08NCT07226895

4 results · Page 1 of 1

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beth Israel Deaconess Medical CenterBostonUnited States45
Columbia UniversityNew YorkUnited States154
Icahan School of Medicine at Mount SinaiNew YorkUnited States1
Northwell HealthGlen OaksUnited States2
Ohio State UniversityColumbusUnited States169
Prevention Science InstituteEugeneUnited States3
Temple UniversityPhiladelphiaUnited States14
University of CaliforniaLos AngelesUnited States11
University of California, IrvineIrvineUnited States32
University of California, San FranciscoSan FranciscoUnited States10
University of North Carolina At Chapel HillChapel HillUnited States50
University of PennsylvaniaPhiladelphiaUnited States507
University of Pittsburgh School of MedicinePittsburghUnited States8
Washington UniversitySt LouisUnited States182
Yale University Conneticut Mental Health CenterNew HavenUnited States1